Amgen : AMGN

All Amgen Articles

699 Articles

247sarah | May 6, 2020 at 9:30 AM EDT

Why Borrowing $8.5 Billion Won’t Impact Apple Stock

Apple borrowed $8.5 billion Monday in a four-part bond deal. Why? Because right now, money is cheap.

Chris Lange | Apr 27, 2020 at 8:47 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The April 15 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Apr 13, 2020 at 9:40 AM EDT

Big Biotechs Scare Off Short Sellers

The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech…

Jon C. Ogg | Mar 30, 2020 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Amgen, Cerner, eBay, Gap, Nike, Nucor, P&G, TJX, ViacomCBS and More

Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Amgen, Cerner, eBay, Gap, Nike, Nucor, Procter & Gamble, TJX and…

Chris Lange | Mar 25, 2020 at 9:45 AM EDT

Major Biotechs Get Mixed Message on Short Interest

The March 13 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Mar 11, 2020 at 9:13 AM EDT

Big Biotechs Have Short Sellers Confused

The February 28 short interest data has been compared with the previous report, and short interest moves in these selected…

Chris Lange | Feb 27, 2020 at 8:35 AM EST

Major Biotechs Have Short Sellers Confused

The February 14 short interest data has been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Feb 20, 2020 at 7:35 AM EST

15 Top ESG Stocks That Look Undervalued for 2020

With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks…

Chris Lange | Feb 12, 2020 at 8:45 AM EST

Biotech Short Sellers Focus on a Couple Favorites

The January 31 data has been compared with the previous report, and short interest in most of these selected biotech…

Jon C. Ogg | Feb 6, 2020 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive,…

Jon C. Ogg | Feb 3, 2020 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta…

Jon C. Ogg | Jan 31, 2020 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AGNC, Amazon, Amgen, Coca-Cola, Danaher, EA, IBM, Miragen, Proofpoint, Sprint, UPS, Uber, Vertex, Visa and More

Friday's top analyst upgrades, downgrades and initiations included Amazon.com, Amgen, Coca-Cola, Danaher, Electronic Arts, IBM, Proofpoint, Sprint, UPS, Uber, Vertex…

Chris Lange | Jan 28, 2020 at 8:45 AM EST

Short Sellers Wary on Major Biotechs

The January 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Jan 26, 2020 at 7:10 AM EST

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and…

Chris Lange | Jan 23, 2020 at 1:35 PM EST

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.

1 … 9 10 11 12 13 … 47

Amgen : AMGN

All Amgen Articles

Why Borrowing $8.5 Billion Won’t Impact Apple Stock

Short Sellers Grow More Selective on Major Biotechs

Big Biotechs Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Amgen, Cerner, eBay, Gap, Nike, Nucor, P&G, TJX, ViacomCBS and More

Major Biotechs Get Mixed Message on Short Interest

Big Biotechs Have Short Sellers Confused

Major Biotechs Have Short Sellers Confused

15 Top ESG Stocks That Look Undervalued for 2020

Biotech Short Sellers Focus on a Couple Favorites

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Top Analyst Upgrades and Downgrades: AGNC, Amazon, Amgen, Coca-Cola, Danaher, EA, IBM, Miragen, Proofpoint, Sprint, UPS, Uber, Vertex, Visa and More

Short Sellers Wary on Major Biotechs

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

How Earnings Will Dictate Biotech Sector’s Fate in 2020

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Amgen : AMGN

All Amgen Articles

Why Borrowing $8.5 Billion Won’t Impact Apple Stock

Short Sellers Grow More Selective on Major Biotechs

Big Biotechs Scare Off Short Sellers

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Amgen, Cerner, eBay, Gap, Nike, Nucor, P&G, TJX, ViacomCBS and More

Major Biotechs Get Mixed Message on Short Interest

Big Biotechs Have Short Sellers Confused

Major Biotechs Have Short Sellers Confused

15 Top ESG Stocks That Look Undervalued for 2020

Biotech Short Sellers Focus on a Couple Favorites

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More

Top Analyst Upgrades and Downgrades: AGNC, Amazon, Amgen, Coca-Cola, Danaher, EA, IBM, Miragen, Proofpoint, Sprint, UPS, Uber, Vertex, Visa and More

Short Sellers Wary on Major Biotechs

Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week

How Earnings Will Dictate Biotech Sector’s Fate in 2020

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%